Hologic Inc. (HOLX): Price and Financial Metrics

Hologic Inc. (HOLX): $76.35

0.44 (+0.58%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

B

HOLX Price/Volume Stats

Current price $76.35 52-week high $87.88
Prev. close $75.91 52-week low $64.02
Day low $75.64 Volume 1,500,900
Day high $76.81 Avg. volume 1,898,926
50-day MA $74.22 Dividend yield N/A
200-day MA $73.77 Market Cap 17.92B

HOLX Stock Price Chart Interactive Chart >

HOLX POWR Grades

  • HOLX scores best on the Quality dimension, with a Quality rank ahead of 89.42% of US stocks.
  • HOLX's strongest trending metric is Quality; it's been moving down over the last 26 weeks.
  • HOLX's current lowest rank is in the Momentum metric (where it is better than 24.39% of US stocks).

HOLX Stock Summary

  • HOLX has a higher market value than 87.98% of US stocks; more precisely, its current market capitalization is $17,369,002,781.
  • HOLX's went public 33.8 years ago, making it older than 84.83% of listed US stocks we're tracking.
  • Revenue growth over the past 12 months for HOLOGIC INC comes in at -17.12%, a number that bests merely 15.64% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to HOLX, based on their financial statements, market capitalization, and price volatility, are LOGI, GNRC, PAYC, RMD, and HXL.
  • Visit HOLX's SEC page to see the company's official filings. To visit the company's web site, go to www.hologic.com.

HOLX Valuation Summary

  • HOLX's price/earnings ratio is 37.6; this is 28.99% higher than that of the median Healthcare stock.
  • HOLX's price/sales ratio has moved up 2.5 over the prior 243 months.

Below are key valuation metrics over time for HOLX.

Stock Date P/S P/B P/E EV/EBIT
HOLX 2023-12-29 4.3 3.4 37.6 21.9
HOLX 2023-12-28 4.2 3.4 37.5 21.9
HOLX 2023-12-27 4.2 3.4 37.3 21.8
HOLX 2023-12-26 4.2 3.4 37.4 21.8
HOLX 2023-12-22 4.2 3.4 37.4 21.8
HOLX 2023-12-21 4.2 3.4 37.4 21.8

HOLX Growth Metrics

    Its year over year revenue growth rate is now at 1.4%.
  • The 4 year price growth rate now stands at 6.51%.
  • The 2 year net income to common stockholders growth rate now stands at 242.78%.
HOLX's revenue has moved up $1,140,900,000 over the prior 34 months.

The table below shows HOLX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 4,465.8 1,814.9 990.2
2022-09-30 4,862.8 2,125.7 1,302
2022-06-30 5,226.1 2,422.5 1,512.1
2022-03-31 5,391.7 2,754.6 1,552.1
2021-12-31 5,493.6 2,244.6 1,716.3
2021-09-30 5,632.3 2,330.4 1,871.5

HOLX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • HOLX has a Quality Grade of B, ranking ahead of 93.54% of graded US stocks.
  • HOLX's asset turnover comes in at 0.722 -- ranking 49th of 186 Medical Equipment stocks.
  • SNN, TTOO, and AVGR are the stocks whose asset turnover ratios are most correlated with HOLX.

The table below shows HOLX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-26 0.722 0.689 0.596
2021-03-27 0.719 0.689 0.566
2020-12-26 0.639 0.656 0.430
2020-09-26 0.557 0.590 0.268
2020-06-27 0.500 0.469 0.097
2020-03-28 0.510 0.458 0.087

HOLX Price Target

For more insight on analysts targets of HOLX, see our HOLX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $85.50 Average Broker Recommendation 1.38 (Strong Buy)

Hologic Inc. (HOLX) Company Bio


Hologic, Inc. is a medical technology company primarily focused on women’s health; it sells medical devices for diagnosticssurgery, and medical imaging. (Source:Wikipedia)


HOLX Latest News Stream


Event/Time News Detail
Loading, please wait...

HOLX Latest Social Stream


Loading social stream, please wait...

View Full HOLX Social Stream

Latest HOLX News From Around the Web

Below are the latest news stories about HOLOGIC INC that investors may wish to consider to help them evaluate HOLX as an investment opportunity.

The Zacks Analyst Blog Highlights DaVita, GE HealthCare Technologies and Hologic

DaVita, GE HealthCare Technologies and Hologic are part of the Zacks top Analyst Blog.

Yahoo | December 28, 2023

Here’s Why You Should Add Hologic (HOLX) to Your Portfolio

ClearBridge Investments, an investment management company, released its “ClearBridge Sustainability Leaders Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here. The strategy underperformed its benchmark, the Russell 3000 Index, in the quarter. The strategy gained two out of 10 sectors in which it invested during the quarter, on an absolute […]

Yahoo | December 28, 2023

Hologic (HOLX) Stock Falls Amid Market Uptick: What Investors Need to Know

Hologic (HOLX) closed the most recent trading day at $70.94, moving -0.24% from the previous trading session.

Yahoo | December 27, 2023

3 Beaten-Down MedTech Stocks Poised for a Turnaround in 2024

Here are some dirt-cheap MedTech value stocks - DVA, GEHC, HOLX - which are expected to provide long-term gains.

Yahoo | December 27, 2023

Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.

Yahoo | December 27, 2023

Read More 'HOLX' Stories Here

HOLX Price Returns

1-mo 3.47%
3-mo 8.58%
6-mo 8.96%
1-year -2.50%
3-year 6.00%
5-year 60.00%
YTD 6.86%
2023 -4.49%
2022 -2.29%
2021 5.12%
2020 39.49%
2019 27.03%

Continue Researching HOLX

Want to see what other sources are saying about Hologic Inc's financials and stock price? Try the links below:

Hologic Inc (HOLX) Stock Price | Nasdaq
Hologic Inc (HOLX) Stock Quote, History and News - Yahoo Finance
Hologic Inc (HOLX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!